This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (6) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Pol, A. Articles by Schalkwijk, J. Search for Related Content PubMed PubMed Citation Articles by Pol, A. Articles by Schalkwijk, J. Social Bookmarking                   What's this?

Development of a Keratinocyte-Based Screening Model for Antipsoriatic Drugs Using Green Fluorescent Protein Under the Control of an Endogenous Promoter

Department of Dermatology, University Medical Center St. Radboud, Nijmegen, The Netherlands

Fred Van Ruissen

Department of Dermatology, University Medical Center St. Radboud, Nijmegen, The Netherlands

Joost Schalkwijk

Department of Dermatology, University Medical Center St. Radboud, Nijmegen, The Netherlands

Inflamed epidermis (psoriasis, wound healing, ultraviolet-irradiated skin) harbors keratinocytes that are hyperproliferative and display an abnormal differentiation program. A distinct feature of this so-called regenerative maturation pathway is the expression of proteins such as the cytokeratins CK6, CK16, and CK17 and the antiinflammatory protein SKALP/elafin. These proteins are absent in normal skin but highly induced in lesional psoriatic skin. Expression of these genes can be used as a surrogate marker for psoriasis in drug-screening procedures of large compound libraries. The aim of this study was to develop a keratinocyte cell line that contained a reporter gene under the control of a psoriasis-associated endogenous promoter and demonstrate its use in an assay suitable for screening. We generated a stably transfected keratinocyte cell line that expresses enhanced green fluorescent protein (EGFP), under the control of a 0.8-kb fragment derived from the promoter of the SKALP/elafin gene, which confers high levels of tissue-specific expression at the mRNA level. Induction of the SKALP promoter by tumor necrosis factor-ca resulted in increased expression levels of the secreted SKALP-EGFP fusion protein as assessed by direct readout of fluorescence and fluorescence polarization in 96-well cell culture plates. The fold stimulation of the reporter gene was comparable to that of the endogenous SKALP gene as assessed by enzyme-linked immunosorbent assay. Although the dynamic range of the screening system is limited, the small standard deviation yields a Z factor of 0.49. This indicates that the assay is suitable as a high-throughput screen, and provides proof of the concept that a secreted EGFP fusion protein under the control of a physiologically relevant endogenous promoter can be used as a fluorescence-based high-throughput screen for differentiation-modifying or antiinflammatory compounds that act via the keratinocyte.

Journal of Biomolecular Screening, Vol. 7, No. 4, 325-332 (2002)
DOI: 10.1177/108705710200700404


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Honma, M. Stubbs, I. Collins, P. Workman, W. Aherne, and F. M. Watt Identification of Novel Keratinocyte Differentiation Modulating Compounds by High-Throughput Screening J Biomol Screen, December 1, 2006; 11(8): 977 - 984. [Abstract] [PDF]

				C. E. Hellweg, C. Baumstark-Khan, and G. Horneck Generation of Stably Transfected Mammalian Cell Lines as Fluorescent Screening Assay for NF- B Activation-Dependent Gene Expression J Biomol Screen, October 1, 2003; 8(5): 511 - 521. [Abstract] [PDF]